These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28760675)
21. Determination of polysorbate in ascites fluid from a premature infant. McKean DL; Pesce AJ J Anal Toxicol; 1985; 9(4):174-6. PubMed ID: 4033075 [TBL] [Abstract][Full Text] [Related]
22. Characterization of polysorbate 80 with liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy: specific determination of oxidation products of thermally oxidized polysorbate 80. Hvattum E; Yip WL; Grace D; Dyrstad K J Pharm Biomed Anal; 2012 Mar; 62():7-16. PubMed ID: 22260967 [TBL] [Abstract][Full Text] [Related]
23. Quantitation of low concentrations of polysorbates in high protein concentration formulations by solid phase extraction and cobalt-thiocyanate derivatization. Kim J; Qiu J Anal Chim Acta; 2014 Jan; 806():144-51. PubMed ID: 24331050 [TBL] [Abstract][Full Text] [Related]
24. Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time. Graf T; Abstiens K; Wedekind F; Elger C; Haindl M; Wurth C; Leiss M Eur J Pharm Biopharm; 2020 Jul; 152():318-326. PubMed ID: 32445968 [TBL] [Abstract][Full Text] [Related]
25. Fast and sensitive determination of Polysorbate 80 in solutions containing proteins. Fekete S; Ganzler K; Fekete J J Pharm Biomed Anal; 2010 Sep; 52(5):672-9. PubMed ID: 20307948 [TBL] [Abstract][Full Text] [Related]
26. The Characterization of Polysorbate. Zhang S; Xiao H; Li N Curr Protoc; 2022 Jul; 2(7):e489. PubMed ID: 35857882 [TBL] [Abstract][Full Text] [Related]
27. Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques. Mahler HC; Printz M; Kopf R; Schuller R; Müller R J Pharm Sci; 2008 Feb; 97(2):764-74. PubMed ID: 17688279 [TBL] [Abstract][Full Text] [Related]
28. Stability of the non-ionic surfactant polysorbate 80 investigated by HPLC-MS and charged aerosol detector. Christiansen A; Backensfeld T; Kühn S; Weitschies W Pharmazie; 2011 Sep; 66(9):666-71. PubMed ID: 22026121 [TBL] [Abstract][Full Text] [Related]
29. Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes. Dwivedi M; Blech M; Presser I; Garidel P Int J Pharm; 2018 Dec; 552(1-2):422-436. PubMed ID: 30300706 [TBL] [Abstract][Full Text] [Related]
30. Novel markers to track oxidative polysorbate degradation in pharmaceutical formulations. Dahotre S; Tomlinson A; Lin B; Yadav S J Pharm Biomed Anal; 2018 Aug; 157():201-207. PubMed ID: 29803911 [TBL] [Abstract][Full Text] [Related]
31. High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during Biopharmaceutical Development. Bhargava AC; Mains K; Siu A; Gu J; Zarzar J; Yi L; Yuk IH Pharm Res; 2021 Mar; 38(3):397-413. PubMed ID: 33655394 [TBL] [Abstract][Full Text] [Related]
32. Clinical-Grade Oncolytic Adenovirus Purification Using Polysorbate 20 as an Alternative for Cell Lysis. Moleirinho MG; Rosa S; Carrondo MJT; Silva RJS; Hagner-McWhirter Å; Ahlén G; Lundgren M; Alves PM; Peixoto C Curr Gene Ther; 2018; 18(6):366-374. PubMed ID: 30411681 [TBL] [Abstract][Full Text] [Related]
33. Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80. Hewitt D; Alvarez M; Robinson K; Ji J; Wang YJ; Kao YH; Zhang T J Chromatogr A; 2011 Apr; 1218(15):2138-45. PubMed ID: 20950816 [TBL] [Abstract][Full Text] [Related]
34. [Determination of polysorbate 80 in Reduning injection by HGPC-ELSD]. Shen J; Zhang Q; Li JC; Bi YA; Wang ZZ; Xiao W Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2915-7. PubMed ID: 25423832 [TBL] [Abstract][Full Text] [Related]
35. Use of ferric thiocyanate derivatization for quantification of polysorbate 80 in high concentration protein formulations. Savjani N; Babcock E; Khor HK; Raghani A Talanta; 2014 Dec; 130():542-6. PubMed ID: 25159444 [TBL] [Abstract][Full Text] [Related]
36. Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay. Lippold S; Koshari SHS; Kopf R; Schuller R; Buckel T; Zarraga IE; Koehn H J Pharm Biomed Anal; 2017 Jan; 132():24-34. PubMed ID: 27693757 [TBL] [Abstract][Full Text] [Related]
37. [Kinetic spectrophotometric study on hemolytic process of polysorbate 80]. Zhang SF; Yan D; Tang HY; Luo Y; Zhang P; Yang M; Wang YS; Xiao XH Yao Xue Xue Bao; 2010 Apr; 45(4):535-8. PubMed ID: 21355224 [TBL] [Abstract][Full Text] [Related]
38. Human Serum Albumin Mitigates Formation of Fatty Acid Particles in Polysorbate-Containing Solutions. Kim DM; Stansberry-Perkins K; Marlow MS; Pyles EA J Pharm Sci; 2022 Nov; 111(11):3185-3188. PubMed ID: 35977591 [TBL] [Abstract][Full Text] [Related]
39. Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway. Saggu M; Liu J; Patel A Pharm Res; 2015 Sep; 32(9):2877-88. PubMed ID: 25773722 [TBL] [Abstract][Full Text] [Related]
40. Hydrolytic polysorbate 20 degradation - Sensitive detection of free fatty acids in biopharmaceuticals via UPLC-QDa analytics with isolator column. Evers DH; Carle S; Lakatos D; Hämmerling F; Garidel P; Buske J J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122717. PubMed ID: 33975273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]